Duke Street Bio develops medical drugs intended to provide improved treatment to cancer patients.
Duke Street Bio has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Duke Street Bio is headquartered in London, United Kingdom.
Duke Street Bio develops medical drugs intended to provide improved treatment to cancer patients.
Duke Street Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Duke Street Bio — Funding & Investors." VCBacked, January 16, 2024, https://www.vcbacked.co/company/duke-street-bio. Accessed September 30, 2026.
VCBacked. (2024). Duke Street Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/duke-street-bio
{{cite web |title=Duke Street Bio — Funding & Investors |url=https://www.vcbacked.co/company/duke-street-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated